|
|
Hyundai Pharmaceutical Co Ltd
KRX •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 06/19/2026
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeKRX
Market Capitalization177,151 mln
Float14.90 mln
Key Fundamentals
EPS217
P/E37.56
ROE4.63
RPS7,446
ROIC3.71
ROA2.40
Interest Cover3.83
EBITDA, mln11,605
EV / EBITDA18.32
EV / EBIT29.94
Revenue, mln195,158
EV / Revenue1.10
Financial Strength
Altman Z-Score2.71
Piotroski F-Score
5
/ 9
Beneish M-Score-1.91
Price to Intrinsic Value2.36
Price to Lynch Fair Value2.49
Price to Graham Number1.17
Shiller PE Ratio225
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
42.23% |
100
/ 100
 |
| 1 Month |
9.84% |
89
/ 100
 |
| 2 Months |
-14.12% |
41
/ 100
 |
| 6 Months |
33.72% |
82
/ 100
 |
| 1 Year |
131% |
88
/ 100
|
|
| |
